Group

The global canagliflozin market is growing due to the increasing number of people with type 2 diabetes. Canagliflozin is a medicine that helps control blood sugar levels by removing excess glucose through urine. It also supports weight management and reduces the risk of heart and kidney problems in diabetic patients. The rise in unhealthy lifestyles and obesity has increased the demand for effective diabetes treatments. Pharmaceutical companies are focusing on research and new product developments to improve canagliflozin’s benefits and safety. As awareness about diabetes care grows, the global canagliflozin market is expected to expand steadily in the coming years.